首页> 美国卫生研究院文献>Journal of Clinical Microbiology >Rapid Antimicrobial Susceptibility Determination of Uropathogens in Clinical Urine Specimens by Use of ATP Bioluminescence
【2h】

Rapid Antimicrobial Susceptibility Determination of Uropathogens in Clinical Urine Specimens by Use of ATP Bioluminescence

机译:利用ATP生物发光技术快速测定尿液中细菌致病菌的抗药性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

We describe the first direct testing of the antimicrobial susceptibilities of bacterial pathogens in human clinical fluid samples by the use of ATP bioluminescence. We developed an ATP bioluminescence assay that eliminates somatic sources of ATP to selectively quantify the bacterial load in clinical urine specimens with a sensitivity of <1,000 CFU per milliliter. There was a log-log relationship between light emission and the numbers of CFU in clinical urine specimens. A clinical study was performed to evaluate the accuracy of the ATP bioluminescence assay for determination of the antimicrobial susceptibilities of uropathogens in clinical urine specimens tested in a blinded manner. ATP bioluminescent bacterial density quantitation was used to determine the inoculation volume in growth medium with and without antibiotics. After incubation at 37°C for 120 min, the ATP bioluminescence assay was repeated to evaluate the uropathogen response to antibiotics. The ability of the ATP bioluminescence assay to discriminate between antimicrobial susceptibility and resistance was determined by comparison of the results obtained by the ATP bioluminescence assay with the results obtained by standard clinical microbiology methods. Receiver operator characteristic curves were used to determine the optimal threshold for discriminating between susceptibility and resistance. Susceptibility and resistance were correctly predicted in 87% and 95% of cases, respectively, for an overall unweighted accuracy of 91%, when the results were stratified by antibiotic. For samples in which the pathogen was susceptible, the accuracy improved to 95% when the results for samples with less than a 25-fold increase in the amount of bacterial ATP in the medium without antibiotics were excluded. These data indicate that a rapid bioluminescent antimicrobial susceptibility assay may be useful for the management of urinary tract infections.
机译:我们描述了通过使用ATP生物发光技术对人类临床体液样品中细菌病原体的抗菌药敏性的首次直接测试。我们开发了一种ATP生物发光测定法,该测定法消除了ATP的体细胞来源,从而选择性地量化了临床尿液样本中的细菌载量,其灵敏度<1,000 CFU /毫升。临床尿液样本中的发光与CFU数量之间存在对数对数关系。进行了一项临床研究,以评估ATP生物发光测定法的准确性,以测定以盲法测试的临床尿液样本中尿路致病菌的抗菌敏感性。 ATP生物发光细菌密度定量用于确定在有或没有抗生素的生长培养基中的接种量。在37°C下温育120分钟后,重复进行ATP生物发光测定以评估尿毒原对抗生素的反应。通过比较由ATP生物发光测定获得的结果与通过标准临床微生物学方法获得的结果,来确定ATP生物发光测定区分抗菌药敏感性和耐药性的能力。接收机操作员特性曲线用于确定区分磁化率和电阻的最佳阈值。当对结果进行抗生素分层时,分别正确预测了87%和95%的病例的药敏性和耐药性,总体未加权准确度为91%。对于其中病原体易感的样品,当排除不含抗生素的培养基中细菌ATP含量增加不到25倍的样品的结果时,准确度提高到95%。这些数据表明,快速的生物发光抗菌药敏试验可用于管理尿路感染。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号